<DOC>
	<DOCNO>NCT00000134</DOCNO>
	<brief_summary>To compare relative merit three therapeutic regimen patient AIDS CMV retinitis previously treat whose retinitis either nonresponsive relapse . These three therapeutic regimen ( 1 ) foscarnet , ( 2 ) high-dose ganciclovir , ( 3 ) combination foscarnet ganciclovir . To compare two treatment strategy patient relapse nonresponsive CMV retinitis : ( 1 ) continue anti-CMV drug ( 2 ) switch alternate drug .</brief_summary>
	<brief_title>Studies Ocular Complications AIDS ( SOCA ) -- Cytomegalovirus Retinitis Retreatment Trial ( CRRT )</brief_title>
	<detailed_description>CMV retinitis common intraocular infection patient AIDS estimate affect 35 40 percent patient AIDS . Untreated CMV retinitis progressive disorder , end result total retinal destruction blindness . At time trial , drug approve United States Food Drug Administration ( FDA ) treatment CMV retinitis ganciclovir ( Cytovene ) foscarnet ( Foscavir ) . Although retinitis responds well initial therapy systemically administer drug , give enough time , nearly patient suffer relapse retinitis . Relapsed retinitis generally respond reinduction maintenance therapy , interval successive relapse progressively shortens . The CRRT address issue management relapse CMV retinitis . The CRRT multicenter , randomize , control clinical trial compare three regimen patient relapse retinitis . Patients AIDS CMV retinitis relapse nonresponsive initial therapy randomize one three regimen : ( 1 ) intravenous foscarnet reinduction 90 mg/kg twice daily 2 week , follow maintenance therapy 120 mg/kg/day ; ( 2 ) intravenous ganciclovir reinduction 5 mg/kg twice daily 2 week follow maintenance 10 mg/kg/day ; ( 3 ) combination therapy , wherein patient continue previous therapy reinduced second drug place maintenance therapy foscarnet 90 mg/kg/day ganciclovir 5 mg/kg/day .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Cytomegalovirus Retinitis</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Foscarnet</mesh_term>
	<mesh_term>Phosphonoacetic Acid</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>inclusion criterion : Males female eligible CRRT must age 18 year old AIDS CMV retinitis . They must active CMV despite minimum 28 day previous treatment antiCMV drug . Furthermore , must absolute neutrophil count great equal 500 cells/µL , platelet count great equal 20,000 cells/µL , serum creatinine &lt; 2.5 mg/dL order tolerate drug regimen . exclusion criterion : history intolerance ganciclovir foscarnet , history therapy involve combination foscarnet ganciclovir , unwillingness practice appropriate birth control , active drug alcohol abuse , medium opacity , retinal detachment schedule surgical repair</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>